Inactive Instrument

Teva Pharmaceutical Industries Limited Stock TEL AVIV STOCK EXCHANGE

Equities

IL0006290147

Pharmaceuticals

Sales 2024 * 15.96B 58.75B Sales 2025 * 16.55B 60.88B Capitalization 18.84B 69.31B
Net income 2024 * 816M 3B Net income 2025 * 1.46B 5.38B EV / Sales 2024 * 2.12 x
Net Debt 2024 * 14.99B 55.15B Net Debt 2025 * 12.47B 45.89B EV / Sales 2025 * 1.89 x
P/E ratio 2024 *
17.5 x
P/E ratio 2025 *
12.1 x
Employees -
Yield 2024 *
-
Yield 2025 *
-
Free-Float 91.44%
More Fundamentals * Assessed data
Dynamic Chart
Teva Pharmaceutical Gains FDA Approval for Daily Huntington's Disease Pill MT
Teva Pharmaceutical Industries Limited Announces AUSTEDO® XR (deutetrabenazine) Extended-Release Tablets Now U.S. FDA Approved as a One Pill, Once-Daily Treatment Option for Clinically Therapeutic Doses (24?48 mg/day) CI
Teva Pharmaceutical Industries Limited and Alvotech Announce SIMLANDI® Injection Now Available in the U.S CI
Teva Pharmaceutical Industries Insider Sold Shares Worth $470,794, According to a Recent SEC Filing MT
Teva Pharmaceutical Industries Insider Sold Shares Worth $254,807, According to a Recent SEC Filing MT
Teva Pharmaceutical Industries Limited Announces Management Changes, Effective June 3, 2024 CI
Transcript : Teva Pharmaceutical Industries Limited Presents at Bank of America Health Care Conference 2024, May-14-2024 08:40 AM
Piper Sandler Adjusts Price Target on Teva Pharmaceutical Industries to $20 From $19, Maintains Overweight Rating MT
Sector Update: Health Care Stocks Slipping Wednesday Afternoon MT
Teva Pharmaceutical Shares Rise After Reporting Higher Q1 Earnings, Revenue; 2024 Guidance Reaffirmed MT
Sector Update: Health Care Stocks Lean Lower Pre-Bell Wednesday MT
Sector Update: Health Care MT
Teva Pharmaceutical Industries Q1 Non-GAAP Earnings, Revenue Rise; 2024 Guidance Reaffirmed MT
Earnings Flash (TEVA) TEVA PHARMACEUTICAL INDUSTRIES LIMITED Posts Q1 Revenue $3.82B MT
Earnings Flash (TEVA) TEVA PHARMACEUTICAL INDUSTRIES LIMITED Posts Q1 EPS $0.48 MT
More news
Managers TitleAgeSince
Chief Executive Officer 55 22-12-31
Director of Finance/CFO 51 19-12-21
Compliance Officer - 09-12-31
Members of the board TitleAgeSince
Director/Board Member 77 15-08-31
Director/Board Member 59 20-06-08
Chairman 76 14-12-31
More insiders
Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.
Calendar
More about the company